乳腺放疗心脏剂量的近期趋势与预测因素:大型质量联盟分析
该研究纳入2012至2015年20家机构4688例全乳放疗乳腺癌患者,分析心脏平均剂量(MHD)变化及影响因素。左侧乳腺癌常规分割MHD中位数从2012年2.19 Gy降至2015年1.65 Gy(P<.001),加速分割从1.70 Gy降至1.22 Gy(P<.001)。深吸气屏气与俯卧位显著降低MHD,而IMRT、瘤床加量、淋巴结放疗及较早年治疗显著增加MHD。
要点
- 左侧乳腺癌常规分割MHD中位数从2012年2.19 Gy降至2015年1.65 Gy。
- 深吸气屏气与俯卧位均显著降低常规和加速分割的MHD。
- IMRT、瘤床加量、淋巴结放疗及2015年前治疗显著增加MHD。
核心结论
- 左侧乳腺癌放疗的MHD在4年间下降,与放疗界及州联盟对心脏保护的关注增加同步。
- 系统监测心脏剂量可能对降低MHD有正面作用。
研究设计与样本
- 2012至2015年,20家参与州联盟的机构纳入4688例接受全乳放疗的乳腺癌患者进入登记研究。
- 采用回归模型评估常规与加速分割下技术、深吸气屏气、体位、淋巴结放疗及瘤床加量对MHD的影响。
主要发现
- 左侧乳腺癌常规分割MHD中位数2012年为2.19 Gy,2015年为1.65 Gy(P<.001)。
- 左侧乳腺癌加速分割MHD中位数2012年为1.70 Gy,2015年为1.22 Gy(P<.001)。
- 常规分割下,锁骨上或锁骨下淋巴结放疗使MHD增加17.1%,内乳淋巴结放疗增加40.7%,瘤床加量增加20.9%,2015年前治疗增加7.7%,IMRT增加20.8%,分离每增加1 cm(相对22 cm)增加1.5%。
- 加速分割下,瘤床加量使MHD增加20.0%,2015年前治疗增加8.5%,IMRT增加19.2%,分离每增加1 cm增加1.7%。
- 深吸气屏气和俯卧位在两种分割方式下均显著降低MHD。
临床怎么用
- 左侧乳腺癌放疗应优先考虑深吸气屏气或俯卧位以降低心脏剂量。
- 需关注IMRT、瘤床加量及淋巴结放疗对MHD的增加效应并个体化权衡。
- 系统监测心脏剂量可能有助于持续降低MHD。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Limited data exist regarding the range of heart doses received in routine practice with radiation therapy (RT) for breast cancer in the United States today and the potential effect of the continual assessment of the cardiac dose on practice patterns. METHODS AND MATERIALS: From 2012 to 2015, 4688 patients with breast cancer treated with whole breast RT at 20 sites participating in a state-wide consortium were enrolled into a registry. The importance of limiting the cardiac dose has been emphasized in the consortium since 2012, and the mean heart dose (MHD) has been reported by each institution since 2014. The effects on the MHD were estimated for both conventional and accelerated fractionation using regression models, with technique (intensity modulated RT [IMRT] vs 3-dimensional conformal RT), deep inspiration breath hold use, patient position (supine vs prone), nodal RT (if delivered), and boost (yes vs no) as covariates. RESULTS: For left-sided breast cancer treated with conventional fractionation, the median MHD in 2012 was 2.19 Gy versus 1.65 Gy in 2015 (P<.001). The factors that significantly increased the MHD for conventional fractionation were increased separation relative to 22 cm (1.5%/1 cm), supraclavicular or infraclavicular nodal RT (17.1%), internal mammary nodal RT (40.7%), use of a boost (20.9%), treatment year before 2015 (7.7%), and use of IMRT (20.8%). For left-sided BC treated with accelerated fractionation, the median MHD in 2012 was 1.70 Gy versus 1.22 Gy in 2015 (P<.001). The factors that significantly increased the MHD for accelerated fractionation were separation (1.7%/1 cm), use of a boost (20.0%), year before 2015 (8.5%), and use of IMRT (19.2%). The factors for both conventional fractionation and accelerated fractionation that significantly reduced the MHD were the use of deep inspiration breath hold and prone positioning. CONCLUSIONS: The MHD for left-sided breast cancer decreased during a recent 4-year period, coincident with an increased focus on cardiac sparing in the radiation oncology community in general and a state-wide consortium specifically. These data suggest a positive effect of systematically monitoring the heart dose delivered.
引用
- Pierce LJ, Feng M, Griffith KA, et al. Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices. Int J Radiat Oncol Biol Phys. 2017. PMID: 28927756. doi:10.1016/j.ijrobp.2017.07.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。